238 related articles for article (PubMed ID: 8491848)
1. Anosognosia in Alzheimer's disease: relationships to depression, cognitive function, and cerebral perfusion.
Reed BR; Jagust WJ; Coulter L
J Clin Exp Neuropsychol; 1993 Mar; 15(2):231-44. PubMed ID: 8491848
[TBL] [Abstract][Full Text] [Related]
2. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
[TBL] [Abstract][Full Text] [Related]
3. Anosognosia and Alzheimer's disease: the role of depressive symptoms in mediating impaired insight.
Smith CA; Henderson VW; McCleary CA; Murdock GA; Buckwalter JG
J Clin Exp Neuropsychol; 2000 Aug; 22(4):437-44. PubMed ID: 10923053
[TBL] [Abstract][Full Text] [Related]
4. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological measures and single photon emission computed tomography in the differentiation and classification of cerebral perfusion deficits in Alzheimer's dementia.
Moren MG; Davis AS; Brinkman JJ; Dean RS
Int J Neurosci; 2005 Aug; 115(8):1131-49. PubMed ID: 16040356
[TBL] [Abstract][Full Text] [Related]
6. Mnemonic anosognosia in Alzheimer's disease: a test of Agnew and Morris (1998).
Ansell EL; Bucks RS
Neuropsychologia; 2006; 44(7):1095-102. PubMed ID: 16324727
[TBL] [Abstract][Full Text] [Related]
7. Memory encoding and retrieval in frontotemporal dementia and Alzheimer's disease.
Glosser G; Gallo JL; Clark CM; Grossman M
Neuropsychology; 2002 Apr; 16(2):190-6. PubMed ID: 11949711
[TBL] [Abstract][Full Text] [Related]
8. [Awareness of deficits and anosognosia in Alzheimer's disease].
Antoine C; Antoine P; Guermonprez P; Frigard B
Encephale; 2004; 30(6):570-7. PubMed ID: 15738860
[TBL] [Abstract][Full Text] [Related]
9. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
10. Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease.
Sabbagh MN; Lynn P; Jhingran S; Massman P; Villanueva-Meyer J; Olup J; Doody RS
J Neuropsychiatry Clin Neurosci; 1997; 9(1):68-74. PubMed ID: 9017531
[TBL] [Abstract][Full Text] [Related]
11. Correlation between anosognosia and regional cerebral blood flow in Alzheimer's disease.
Shibata K; Narumoto J; Kitabayashi Y; Ushijima Y; Fukui K
Neurosci Lett; 2008 Apr; 435(1):7-10. PubMed ID: 18353553
[TBL] [Abstract][Full Text] [Related]
12. Cognitive complaint in mild cognitive impairment and Alzheimer's disease.
Clément F; Belleville S; Gauthier S
J Int Neuropsychol Soc; 2008 Mar; 14(2):222-32. PubMed ID: 18282320
[TBL] [Abstract][Full Text] [Related]
13. Two dimensions of anosognosia in patients with Alzheimer's disease: reliability and validity of the Japanese version of the Anosognosia Questionnaire for Dementia (AQ-D).
Sato J; Nakaaki S; Murata Y; Shinagawa Y; Matsui T; Hongo J; Tatsumi H; Akechi T; Furukawa TA
Psychiatry Clin Neurosci; 2007 Dec; 61(6):672-7. PubMed ID: 18081630
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease.
Vogel A; Hasselbalch SG; Gade A; Ziebell M; Waldemar G
Int J Geriatr Psychiatry; 2005 Mar; 20(3):238-46. PubMed ID: 15717342
[TBL] [Abstract][Full Text] [Related]
15. Some aspects of memory disorders clearly distinguish dementia of the Alzheimer's type from depressive pseudo-dementia.
Gainotti G; Marra C
J Clin Exp Neuropsychol; 1994 Feb; 16(1):65-78. PubMed ID: 8150890
[TBL] [Abstract][Full Text] [Related]
16. Anosognosia in mild Alzheimer's disease is correlated with not only neural dysfunction but also compensation.
Tagai K; Shinagawa S; Kada H; Inamura K; Nagata T; Nakayama K
Psychogeriatrics; 2018 Mar; 18(2):81-88. PubMed ID: 29409154
[TBL] [Abstract][Full Text] [Related]
17. The role of premorbid personality and cognitive factors in awareness of illness, memory, and behavioural functioning in Alzheimer's disease.
Gilleen J; Greenwood K; Archer N; Lovestone S; David AS
Cogn Neuropsychiatry; 2012 May; 17(3):227-45. PubMed ID: 21929281
[TBL] [Abstract][Full Text] [Related]
18. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease.
Wolfe N; Reed BR; Eberling JL; Jagust WJ
Arch Neurol; 1995 Mar; 52(3):257-62. PubMed ID: 7872878
[TBL] [Abstract][Full Text] [Related]
19. A single-photon emission computed tomographic study of anosognosia in Alzheimer's disease.
Starkstein SE; Vázquez S; Migliorelli R; Tesón A; Sabe L; Leiguarda R
Arch Neurol; 1995 Apr; 52(4):415-20. PubMed ID: 7710378
[TBL] [Abstract][Full Text] [Related]
20. Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia.
Huang CW; Chang WN; Huang SH; Lui CC; Chen NC; Chang YT; Lee CC; Chang CC; Chang AY
Eur J Neurol; 2013 Aug; 20(8):1191-7. PubMed ID: 23581395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
